BioCentury
ARTICLE | Financial News

Repurposing play Recursion raises $12.9M

October 3, 2016 7:00 AM UTC

Recursion Pharmaceuticals LLC (Salt Lake City, Utah) raised $12.9 million in a series A round led by Lux Capital. Obvious Ventures, Epic Ventures, Data Collective, AME Cloud Ventures, Wild Basin Investments, and angel investors also participated.

Recursion uses its drug screening platform to identify new purposes for existing compounds including shelved assets. The platform uses statistical and machine learning approaches to evaluate data from high throughput automated screening with high-content assays in human cells, which the company said allows "near simultaneous modeling" of hundreds of diseases, including rare genetic disorders. ...